Campaign

CRO#: 639895

Quadrant Scientific

Medical Device

Quadrant has developed an electromagnetic navigation platform and sensor hardware for image-guided medical procedures beyond the line-of-sight of cameras on surgical tools.
by Dr. Kilian O Donoghue
Cork
27% Funded
€ 350,000 Funding goal
€ 95,431 Invested
34Investors


Company Summary :

 

The company has developed i) a core electromagnetic navigation platform, Deeptrack, which uses ii) Wireless technology and iii) an innovative On-Chip Sensor (OCS) which is smaller, cheaper and more robust than competing products. Quadrant’s innovations can transform many surgical or investigative procedures by providing greater accuracy and speed for clinicians and improving patient safety and cost effectiveness.

 

Key highlights:

  • Company has already earned €500k in consulting fees from manufacturers looking to develop next-generation electromagnetic navigation tools. 
  • Three DTIF grants worth €2.1m secured for R&D. 
  • Sensor manufacturer, Intricon Corp, has invested a total €500k of equity capital in Quadrant in 2023 and 2024.
  • A world-class team of engineering PhDs and commercial expertise in the area of electromagnetic navigation has been put together at Quadrant. 
  • The market for sensor hardware alone is expected to double to €1.7 billion within the next 10 years. 
  • The intellectual property of Quadrant is protected by patent and a 20 year exclusive licence from UCC. 
  • HPSU client with Enterprise Ireland investment of €250k.